Global Information
회사소개 | 문의 | 비교리스트

세계의 심부전용 POC 및 LOC 기기 시장 : 검사 유형, 기술, 최종사용자, 지역별 예측(-2027년) - COVID-19의 누적 영향

Heart Failure POC & LOC Devices Market Research Report by Test Type, Technology, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2022년 07월 상품코드 1104164
페이지 정보 영문 247 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 3,949 ₩ 5,175,000 Online Access - 1 Year (Single User License)
US $ 4,949 ₩ 6,485,000 PDF, Excel & Online Access - 1 Year (Single User License)
US $ 5,949 ₩ 7,796,000 PDF, Excel & Online Access - 1 Year (Up to 5 User License)
US $ 7,949 ₩ 10,417,000 PDF, Excel & Online Access - 1 Year (Site License)
US $ 9,949 ₩ 13,038,000 PDF, Excel & Online Access - 1 Year (Enterprise User License)


세계의 심부전용 POC 및 LOC 기기 시장 : 검사 유형, 기술, 최종사용자, 지역별 예측(-2027년) - COVID-19의 누적 영향 Heart Failure POC & LOC Devices Market Research Report by Test Type, Technology, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
발행일 : 2022년 07월 페이지 정보 : 영문 247 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 심부전용 POC 및 LOC 기기 시장 규모는 2021년에 6,243만 달러, 2022년에 7,429만 달러에 달한 것으로 추정되며, CAGR 19.24%로 성장해 2027년에는 1억 7,951만 달러에 달할 것으로 예측됩니다.

본 보고서는 다음 질문에 대한 답변이 될 것입니다.

  • 세계의 심부전용 POC 및 LOC 기기 시장 시장 규모 및 예측은 어떠한 것인가?
  • 예측기간 중 세계 심부전용 POC&LOC 기기 시장을 형성하는 COVID-19의 저해요인 및 영향은 무엇인가?
  • 심부전용 POC&LOC 기기 세계 시장의 예측기간 중 투자해야 할 제품/부문/용도/영역은 무엇인가?
  • 심부전용 POC&LOC 기기 세계 시장의 경쟁 전략 창은?
  • 심부전용 POC&LOC 기기 세계 시장의 기술 동향과 규제 체계는?
  • 심부전용 POC&LOC 기기 세계 시장 주요 벤더의 시장 점유율은?
  • 심부전용 POC&LOC 기기 세계 시장 참여에 적합한 모드나 전략적 수단은 무엇인가?

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 가정
  • 이해관계자

제2장 조사 방법

  • 정의 : 조사 목적
  • 결정 : 조사 디자인
  • 준비 : 조사표 작성
  • 수집 : 데이터 소스
  • 분석 : 데이터 해석
  • 정식화 : 데이터 검증
  • 출판 : 조사 보고서 작성
  • 반복 : 보고서 업데이트

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 비즈니스 기회
    • 과제
    • COVID-19의 누적 영향

    제6장 심부전용 POC 및 LOC 기기 시장, 검사 유형별

    • 게놈 테스트
    • 대사체 검사
    • 프로테오믹스 검사

    제7장 심부전용 POC 및 LOC 기기 시장, 기술별

    • 어레이 기반 시스템
    • 마이크로플루이딕스

    제8장 심부전용 POC 및 LOC 기기 시장 : 최종사용자별

    • 어시스트 리빙 헬스케어시설
    • 진료소
    • 재택
    • 병원
    • 검사실

    제9장 아메리카의 심부전용 POC 및 LOC 기기 시장

    • 아르헨티나
    • 브라질
    • 캐나다
    • 멕시코
    • 미국

    제10장 아시아태평양의 심부전용 POC 및 LOC 기기 시장

    • 호주
    • 중국
    • 인도
    • 인도네시아
    • 일본
    • 말레이시아
    • 필리핀
    • 싱가포르
    • 한국
    • 대만
    • 태국

    제11장 유럽, 중동 및 아프리카의 심부전용 POC 및 LOC 기기 시장

    • 프랑스
    • 독일
    • 이탈리아
    • 네덜란드
    • 카타르
    • 러시아
    • 사우디아라비아
    • 남아프리카공화국
    • 스페인
    • 아랍에미리트(UAE)
    • 영국

    제12장 경쟁 상황

    • FPNV 포지셔닝 매트릭스
      • 상한
      • 사업 전략
      • 제품 만족도
    • 시장 순위 분석
    • 주요 기업별 시장 점유율 분석
    • 경쟁 시나리오
      • 인수합병(M&A)
      • 계약/협업/파트너십
      • 신제품 출시 및 개선
      • 투자 및 펀딩
      • 수상/표창/확대

    제13장 기업 개요

    • Abbott Laboratories Inc.
    • ACON Laboratories Inc
    • Amgen Inc.
    • AstraZeneca PLC
    • Becton, Dickinson & Company
    • bioMerieux S.A.
    • BODITECH MED INC.
    • Dolphin Corporation
    • Dr. Reddy's Laboratories Ltd
    • F. Hoffmann-La Roche Ltd.
    • Jant Pharmacal Corporation
    • Medtronic PLC
    • Novartis AG
    • PMGroup Worldwide Ltd
    • Samsung Electronics Co Ltd
    • Sanofi S.A.
    • Sekisui Diagnostics, LLC
    • Siemens Healthineers AG
    • Tulip Diagnostics Private Limited
    • Venner Shipley LLP

    제14장 부록

    • 논의 가이드
    • 라이선스와 가격에 대해
    LSH 22.08.03

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2021 VS 2027 (USD MILLION)
  • FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2027
  • FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET DYNAMICS
  • FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
  • FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2027
  • FIGURE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, 2019-2027 (USD MILLION)
  • FIGURE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, 2019-2027 (USD MILLION)
  • FIGURE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, 2019-2027 (USD MILLION)
  • FIGURE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
  • FIGURE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2027
  • FIGURE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, 2019-2027 (USD MILLION)
  • FIGURE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 22. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, 2019-2027 (USD MILLION)
  • FIGURE 23. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 24. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
  • FIGURE 25. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2027
  • FIGURE 27. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, 2019-2027 (USD MILLION)
  • FIGURE 28. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 29. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
  • FIGURE 30. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 31. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, 2019-2027 (USD MILLION)
  • FIGURE 32. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 33. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
  • FIGURE 34. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 35. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, 2019-2027 (USD MILLION)
  • FIGURE 36. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 37. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 38. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 39. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 41. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 42. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 43. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 44. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 45. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 46. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 47. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2027
  • FIGURE 49. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 51. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 53. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 54. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 55. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 56. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 57. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 58. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 59. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 60. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 61. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 62. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 63. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 68. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 69. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 70. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 71. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 72. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 73. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 74. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 75. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 76. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 77. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 78. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 79. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 80. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 7. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 9. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 10. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 12. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 14. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 15. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 17. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 18. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 19. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 22. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 23. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 26. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 27. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 28. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 29. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 31. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 32. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 33. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 34. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 35. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 37. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 38. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 39. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 40. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 42. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 43. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 44. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 45. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 48. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 49. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 50. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 53. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 54. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 55. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 58. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 59. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 60. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 61. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 62. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 63. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 64. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 65. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 66. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 67. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 68. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 69. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 70. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 71. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 72. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 73. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 74. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 75. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 76. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 77. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 78. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 79. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 80. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 81. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 82. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 83. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 89. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 90. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 91. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 92. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 93. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 94. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 95. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 96. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 97. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 98. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 99. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 100. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 101. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 102. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 103. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 104. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 105. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 106. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 107. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 108. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 109. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 110. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 111. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 112. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 113. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 114. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 115. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 116. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 117. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 118. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 119. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 120. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 121. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 122. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 123. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 124. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 125. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 126. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 127. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 128. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 129. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 130. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 131. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 132. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 138. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 139. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 140. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 141. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 142. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 143. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 144. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 145. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 146. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 147. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 148. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 149. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 150. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 151. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 152. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 153. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 154. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 155. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 156. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 157. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 158. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 159. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 160. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 161. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 164. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 165. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 168. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 169. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 170. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 171. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 172. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 173. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 174. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 175. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 176. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 177. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 178. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 179. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
  • TABLE 180. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
  • TABLE 181. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
  • TABLE 182. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 183. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 184. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 185. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET RANKING
  • TABLE 186. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 187. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET MERGER & ACQUISITION
  • TABLE 188. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 189. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 190. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET INVESTMENT & FUNDING
  • TABLE 191. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 192. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: LICENSE & PRICING

The Global Heart Failure POC & LOC Devices Market size was estimated at USD 62.43 million in 2021 and expected to reach USD 74.29 million in 2022, and is projected to grow at a CAGR 19.24% to reach USD 179.51 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Heart Failure POC & LOC Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the market was studied across Genomic Testing, Metabolomic Testing, and Proteomic Testing.

Based on Technology, the market was studied across Array-based Systems and Microfluidics.

Based on End-user, the market was studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratory.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Heart Failure POC & LOC Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Heart Failure POC & LOC Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Heart Failure POC & LOC Devices Market, including Abbott Laboratories Inc., ACON Laboratories Inc, Amgen Inc., AstraZeneca PLC, Becton, Dickinson & Company, bioMerieux S.A., BODITECH MED INC., Dolphin Corporation, Dr. Reddy's Laboratories Ltd, F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Medtronic PLC, Novartis AG, PMGroup Worldwide Ltd, Samsung Electronics Co Ltd, Sanofi S.A., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Tulip Diagnostics Private Limited, and Venner Shipley LLP.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Heart Failure POC & LOC Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heart Failure POC & LOC Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heart Failure POC & LOC Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Heart Failure POC & LOC Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Heart Failure POC & LOC Devices Market?
  • 6. What is the market share of the leading vendors in the Global Heart Failure POC & LOC Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Heart Failure POC & LOC Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for early diagnosis of diseases to reduce healthcare costs
      • 5.1.1.2. Growing development of disposable and low-cost LOC devices with sensors and other accessories
      • 5.1.1.3. Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology to increase research activities for the identification of novel biomarkers
      • 5.1.3.2. Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Reduced accessibility and awareness among the population
  • 5.2. Cumulative Impact of COVID-19

6. Heart Failure POC & LOC Devices Market, by Test Type

  • 6.1. Introduction
  • 6.2. Genomic Testing
  • 6.3. Metabolomic Testing
  • 6.4. Proteomic Testing

7. Heart Failure POC & LOC Devices Market, by Technology

  • 7.1. Introduction
  • 7.2. Array-based Systems
  • 7.3. Microfluidics

8. Heart Failure POC & LOC Devices Market, by End-user

  • 8.1. Introduction
  • 8.2. Assisted Living Healthcare Facilities
  • 8.3. Clinics
  • 8.4. Home
  • 8.5. Hospitals
  • 8.6. Laboratory

9. Americas Heart Failure POC & LOC Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Heart Failure POC & LOC Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories Inc.
  • 13.2. ACON Laboratories Inc
  • 13.3. Amgen Inc.
  • 13.4. AstraZeneca PLC
  • 13.5. Becton, Dickinson & Company
  • 13.6. bioMerieux S.A.
  • 13.7. BODITECH MED INC.
  • 13.8. Dolphin Corporation
  • 13.9. Dr. Reddy's Laboratories Ltd
  • 13.10. F. Hoffmann-La Roche Ltd.
  • 13.11. Jant Pharmacal Corporation
  • 13.12. Medtronic PLC
  • 13.13. Novartis AG
  • 13.14. PMGroup Worldwide Ltd
  • 13.15. Samsung Electronics Co Ltd
  • 13.16. Sanofi S.A.
  • 13.17. Sekisui Diagnostics, LLC
  • 13.18. Siemens Healthineers AG
  • 13.19. Tulip Diagnostics Private Limited
  • 13.20. Venner Shipley LLP

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Back to Top
전화 문의
F A Q